Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 973,131 | 913,929 | 905,050 | 895,937 | 914,607 |
| Cost of Goods | 616,405 | 577,111 | 557,938 | 558,710 | 572,586 |
| Gross Profit | 356,726 | 336,818 | 347,112 | 337,227 | 342,021 |
| Operating Expenses | 169,720 | 188,151 | 175,243 | 182,135 | 205,057 |
| Operating Income | 187,411 | 148,778 | 172,807 | 155,802 | 137,550 |
| Interest Expense | 3,703 | 9,434 | 11,546 | 16,455 | 16,190 |
| Other Income | -39,595 | -28,498 | 2,381 | -16,077 | 6,136 |
| Pre-tax Income | 144,113 | 110,846 | 163,642 | 123,270 | 127,496 |
| Income Tax | 33,449 | 15,620 | 23,815 | 18,111 | 37,580 |
| Net Income Continuous | 110,664 | 95,226 | 139,827 | 105,159 | 89,916 |
| Minority Interests | 1,343 | 2,204 | 2,249 | 1,733 | 1,468 |
| Net Income | $109,321 | $93,022 | $137,578 | $103,426 | $88,448 |
| EPS Basic Total Ops | 2.15 | 1.84 | 2.73 | 2.05 | 1.76 |
| EPS Basic Continuous Ops | 2.18 | 1.88 | 2.78 | 2.09 | 1.79 |
| EPS Diluted Total Ops | 2.13 | 1.81 | 2.67 | 2.01 | 1.72 |
| EPS Diluted Continuous Ops | 2.16 | 1.86 | 2.71 | 2.04 | 1.75 |
| EBITDA(a) | $263,832 | $224,077 | $240,048 | $224,488 | $205,655 |